Assessment | Screening | Baseline | Day 30 |
---|---|---|---|
Eligibility and enrollment | |||
Verbal consent | X | Â | Â |
Prisoner status assessment | X | Â | Â |
Demographics | X | Â | Â |
Eligibility summary | X | Â | Â |
Enrollment (inclusion/exclusion) | X | Â | Â |
General | |||
Written informed consent and medical release | X | Â | Â |
Additional demographics | Â | X | Â |
Locator information form | Â | X | X |
DSM-5 checklist for OUD | Â | X | Â |
Other substance use [21] | Â | X | Â |
EuroQol-5 dimensions (EQ-5D) [22] | Â | X | X |
Motivations, attitudes and expectations | Â | X | Â |
Study completion | Â | Â | X |
Health services | |||
Inpatient utilization | Â | X | X |
Outpatient utilization | Â | X | X |
 | X | X | |
Healthcare visit logistics | Â | X | Â |
ED visit review | Â | X | Â |
ED visits and hospitalizations | Â | Â | X |
Process outcomes | |||
Engagement in treatment | Â | Â | X |
Prescription drug monitoring | Â | Â | X |
Treatment decision | Â | X | Â |
Treatment satisfaction/acceptability | Â | Â | X |
Opioid outcomes | |||
 | X | X | |
Urine drug screen | Â | X | X |
Overdose events and risk factors | Â | X | X |
Safety | |||
Safety events | Â | X | X |